These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37947888)

  • 1. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
    Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
    Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
    Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
    Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
    Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
    Snyder M; Pasikhova Y; Baluch A
    Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
    Perreault S; McManus D; Bar N; Foss F; Gowda L; Isufi I; Seropian S; Malinis M; Topal JE
    Transpl Infect Dis; 2019 Apr; 21(2):e13059. PubMed ID: 30737868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
    Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
    J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
    Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
    Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
    Sipahi OR; Kahraman H; Erdem HA; Yetkin F; Kaya S; Demirdal T; Tunccan OG; Karasahin O; Oruc E; Cag Y; Kurtaran B; Ulug M; Kutlu M; Avci M; Oztoprak N; Arda B; Pullukcu H; Tasbakan M; Yamazhan T; Kandemir O; Dizbay M; Sipahi H; Ulusoy S
    Infection; 2019 Apr; 47(2):259-266. PubMed ID: 30498901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
    Guarana M; Nucci M; Nouér SA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary Tool Kit for Febrile Neutropenia: Stewardship Guidelines,
    Bartash R; Cowman K; Szymczak W; Guo Y; Ostrowsky B; Binder A; Sheridan C; Levi M; Gialanella P; Nori P
    JCO Oncol Pract; 2020 Jul; 16(7):e563-e572. PubMed ID: 32048919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
    Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
    J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
    Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
    J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
    Karandikar MV; Milliren CE; Zaboulian R; Peiris P; Sharma T; Place AE; Sandora TJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):428-436. PubMed ID: 31603472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
    Okubo L; Andrick B; Rampulla R; Leri F
    J Oncol Pharm Pract; 2022 Jun; 28(4):898-903. PubMed ID: 35156879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
    Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
    Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
    Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
    Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.
    Grigg SE; Date P; Loh Z; Estacio O; Johnson DF; Hawkes EA; Grigg A
    Support Care Cancer; 2019 Apr; 27(4):1223-1227. PubMed ID: 30259115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.